The anti-ageing Ozempic effect: How weight loss jabs could help you live longer ‘slashing your risk of dying young’
WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs can’t do? ShutterstockVarious studies have found that Ozempic-like fat jabs can help reduce your risk of chronic illness and leading causes of death[/caption] While a medicine that reverses the clock would be a miracle, we’re not quite there, yet. But scientists […]
How weight-loss jabs like Mounjaro and Ozempic can destroy your pancreas. First the flesh dies… then your organs fail. As they’re linked to ten deaths, doctors’ urgent warning revealed
The MHRA has revealed it’s received more than 560 reports of acute pancreatitis in patients taking GLP-1 injections since they were first approved in the UK.
China clears mazdutide as first dual GCG/GLP-1RA for weight loss
Innovent Biologics Inc. announced June 27 that it gained National Medical Products Administration’s (NMPA) approval of mazdutide as a new weight loss therapy for obese or overweight patients in China. Mazdutide is a dual glucagon/glucagon-like peptide-1 (GCG/GLP-1) receptor agonist originally discovered by Eli Lilly and Co., of Indianapolis.
[Comment] Body composition during major incretin-based weight loss
We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist tirzepatide in people with obesity but without diabetes.1 In people with type 2 diabetes, weight loss seems to be somewhat lower, at 8–9% with semaglutide and 11–13% […]
Liraglutide May Reduce Migraine Burden in Adults With Obesity, Migraine
MONDAY, June 30, 2025 — For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and Migraine Disability Assessment (MIDAS) scores, according to a study presented at the 11th Congress…